now loading...
Wealth Asia Connect Middle East Treasury & Capital Markets Europe ESG Forum TechTalk
Treasury & Capital Markets / On The Move
Citi bolsters healthcare investment banking team
Ben Bartholomaeus to play key advisory and execution roles for Australian and New Zealand healthcare clients
The Asset   20 Mar 2026

Citi has appointed Ben Bartholomaeus as head of healthcare, Australia and New Zealand, part of the capital markets and advisory team. 

Bartholomaeus joins Citi from Goldman Sachs where he also worked as head of healthcare in the corporate advisory division for Australia and New Zealand.

He was instrumental in advising on landmark healthcare transactions, including DBG Health's A$1.6 billion ( US$1.13 billion ) investment from BDT & MSD Partners, the sale of a significant stake in Novotech to GIC and Temasek, and Ramsay Health Care's announced spin-off of its 53% stake in Ramsay Sante.

Bartholomaeus will play an important role in bringing the bank's global connectivity, sector insights, and execution expertise to Australian and New Zealand healthcare clients, Citi says. He will report locally to Australia and New Zealand co-heads of capital markets and advisory Philippe Perzi and Ben Connolly and will be based in the Sydney office. He will also report to Ling Zhang, head of healthcare, Asia-Pacific region.

The appointment bolsters Citi’s strong bench in healthcare banking, with Sumit Khedekar in the role of Citi’s global head of healthcare and Chuck Adams leading the team as global head of healthcare, consumer and retail investment banking.

Citi boasts being the top global adviser in healthcare M&A from 2024 through 2026 year to date and leading major transactions for clients in biopharma, medtech and life science tools/diagnostics sectors. These include Johnson & Johnson’s US$14.6 billion acquisition of Intra-Cellular Therapies, Catalent’s US$16.5 billion sale to Novo Holdings, Blackstone and TPG’s US$18.3 billion acquisition of Hologic, and BD Biosciences and Diagnostic Solutions' US$17.5 billion merger with Waters Corporation.

The current Asia-Pacific pipeline for healthcare is strong, and there is immense opportunity in Australia, the bank says, adding that Bartholomaeus's hiring further reinforces Citi’s commitment to building a best‑in‑class healthcare investment banking platform.

Meanwhile, Kriss Pachauri has joined the team as director of global asset managers for Australia and New Zealand. This builds upon 2025 leadership appointments within the bank's capital markets and advisory division, with Ben Connolly and Philippe Perzi taking on the roles of co-heads of capital markets and advisory and John Mclean being appointed as head of equity capital markets and global asset managers for Australia and New Zealand.